Search

Displaying results 5961 - 5970 of 10000 in total
  1. Drug

    Diflunisal

    go.drugbank.com/drugs/DB00861
    Approved

    Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs. … Diflunisal is used to relieve pain accompanied with inflammation and in the symptomatic treatment of rheumatoid arthritis and osteoarthritis.

  2. Drug

    Olcegepant

    go.drugbank.com/drugs/DB04869
    Investigational

    Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential new approach to the treatment of migraine. … Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks

  3. Drug

    Suramin

    go.drugbank.com/drugs/DB04786
    Investigational

    Suramin is manufactured by Bayer in Germany as Germanin®. … It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca.

  4. Drug

    EVT-101

    go.drugbank.com/drugs/DB05956
    Investigational

  5. Drug

    Inosine 5'-sulfate

    go.drugbank.com/drugs/DB05973
    Experimental

  6. Drug

    Rubitecan

    go.drugbank.com/drugs/DB06159
    Investigational

    Synonyms: 9-nitro-20(S)-camptothecin, 9-nitro-20-(S)-camptothecin
  7. Drug

    Plevitrexed

    go.drugbank.com/drugs/DB06163
    Investigational

  8. Drug

    Sapacitabine

    go.drugbank.com/drugs/DB06365
    Investigational

  9. Drug

    Tanomastat

    go.drugbank.com/drugs/DB06276
    Experimental

  10. Drug

    Pramiconazole

    go.drugbank.com/drugs/DB06295
    Experimental